Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

In my opinion, all the talk about problems of distribution, training, and insurance barriers are BS. This is a pricing issue. Probuphine is too expensive. Period.

Perhaps a solution...

The government maintains rights in any drug developed with federal funds, even when it does not own the patent. Probuphine, a highly effective medication assisted treatment for opioid dependence, is protected by one patent for a discovery made in the course of research financed by the National Institute of Mental Health.

Despite the fact that the government has rights in this treatment, the cost to patients can be $4,000 to $6,000 for a six month supply. The result is that the medication remains inaccessible to patients without insurance, while many insurance companies fail to cover Probuphine as a first line treatment.



http://thehill.com/opinion/healthcare/363322-american-taxpayers-will-be-alex-azars-shareholders-lets-hope-he-can-serve